Analyst Recommendations

Evercore ISI analyst issues OUTPERFORM recommendation for GPN on February 2, 2024 05:58AM ET. GPN was trading at $135.31 at issue of the analyst recommendation.The overall analyst consensus...

February 2, 2024   GPN -1.28%

Raymond James analyst issues OUTPERFORM recommendation for TSCO on February 2, 2024 07:40AM ET. The previous analyst recommendation was Strong Buy.TSCO was trading at $234.9 at issue of...

February 2, 2024   TSCO -1.22%

KeyBanc analyst issues OVERWEIGHT recommendation for META on February 2, 2024 05:46AM ET. The previous analyst recommendation was Overweight.META was trading at $394.78 at issue of the analyst...

February 2, 2024   META 0.47%

Exane BNP Paribas analyst issues NEUTRAL recommendation for CTVA on February 2, 2024 04:02AM ET. CTVA was trading at $54.06 at issue of the analyst recommendation.The overall analyst...

February 2, 2024   CTVA 1.83%

UBS analyst issues BUY recommendation for XOM on February 2, 2024 02:10AM ET. The previous analyst recommendation was Buy.XOM was trading at $102.39 at issue of the analyst...

February 2, 2024   XOM -0.91%

Scotiabank analyst issues PERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Sector Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX 0.30%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA 0.59%

Raymond James analyst issues OUTPERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX 0.30%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA 0.59%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA 0.59%